Safety of MVA-BN vaccine in health-care personnel in DR Congo: a prospective cohort study.
Saved in:
| Title: | Safety of MVA-BN vaccine in health-care personnel in DR Congo: a prospective cohort study. |
|---|---|
| Authors: | Minhaj FS; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: rhu5@cdc.gov., Mandra A; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Nguete BU; Kinshasa School of Public Health, Kinshasa, DR Congo., Likafi T; Ministry of Health, Kinshasa, DR Congo., Kokola G; Ministry of Health, Kinshasa, DR Congo., Tran S; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Kennedy JL; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Monroe B; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Hughes CM; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Joseph T; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Person MK; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Townsend MB; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Satheshkumar PS; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Kabamba J; Centers for Disease Control and Prevention, Kinshasa, DR Congo., Reynolds MG; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Rao AK; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Kasongo D; Ministry of Health, Kinshasa, DR Congo., Yu PA; Office of Readiness and Response, Centers for Disease Control and Prevention, Atlanta, GA, USA., Yu Y; Office of Readiness and Response, Centers for Disease Control and Prevention, Atlanta, GA, USA., Shongo Lushima R; Ministry of Health, Kinshasa, DR Congo., Kaba D; Kinshasa School of Public Health, Kinshasa, DR Congo., Petersen B; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., McCollum AM; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA. |
| Source: | The Lancet. Infectious diseases [Lancet Infect Dis] 2026 Jun; Vol. 26 (6), pp. 561-570. Date of Electronic Publication: 2026 Mar 09. |
| Publication Type: | Clinical Trial, Phase III; Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41819117 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety of MVA-BN vaccine in health-care personnel in DR Congo: a prospective cohort study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Minhaj+FS%22">Minhaj FS</searchLink>; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: rhu5@cdc.gov.<br /><searchLink fieldCode="AU" term="%22Mandra+A%22">Mandra A</searchLink>; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Nguete+BU%22">Nguete BU</searchLink>; Kinshasa School of Public Health, Kinshasa, DR Congo.<br /><searchLink fieldCode="AU" term="%22Likafi+T%22">Likafi T</searchLink>; Ministry of Health, Kinshasa, DR Congo.<br /><searchLink fieldCode="AU" term="%22Kokola+G%22">Kokola G</searchLink>; Ministry of Health, Kinshasa, DR Congo.<br /><searchLink fieldCode="AU" term="%22Tran+S%22">Tran S</searchLink>; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Kennedy+JL%22">Kennedy JL</searchLink>; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Monroe+B%22">Monroe B</searchLink>; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Hughes+CM%22">Hughes CM</searchLink>; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Joseph+T%22">Joseph T</searchLink>; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Person+MK%22">Person MK</searchLink>; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Townsend+MB%22">Townsend MB</searchLink>; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Satheshkumar+PS%22">Satheshkumar PS</searchLink>; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Kabamba+J%22">Kabamba J</searchLink>; Centers for Disease Control and Prevention, Kinshasa, DR Congo.<br /><searchLink fieldCode="AU" term="%22Reynolds+MG%22">Reynolds MG</searchLink>; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Rao+AK%22">Rao AK</searchLink>; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Kasongo+D%22">Kasongo D</searchLink>; Ministry of Health, Kinshasa, DR Congo.<br /><searchLink fieldCode="AU" term="%22Yu+PA%22">Yu PA</searchLink>; Office of Readiness and Response, Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Yu+Y%22">Yu Y</searchLink>; Office of Readiness and Response, Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Shongo+Lushima+R%22">Shongo Lushima R</searchLink>; Ministry of Health, Kinshasa, DR Congo.<br /><searchLink fieldCode="AU" term="%22Kaba+D%22">Kaba D</searchLink>; Kinshasa School of Public Health, Kinshasa, DR Congo.<br /><searchLink fieldCode="AU" term="%22Petersen+B%22">Petersen B</searchLink>; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22McCollum+AM%22">McCollum AM</searchLink>; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101130150%22">The Lancet. Infectious diseases</searchLink> [Lancet Infect Dis] 2026 Jun; Vol. 26 (6), pp. 561-570. <i>Date of Electronic Publication: </i>2026 Mar 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130150 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-4457 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214733099%22">14733099 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41819117 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1473-3099(25)00779-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 561 Titles: – TitleFull: Safety of MVA-BN vaccine in health-care personnel in DR Congo: a prospective cohort study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Minhaj FS – PersonEntity: Name: NameFull: Mandra A – PersonEntity: Name: NameFull: Nguete BU – PersonEntity: Name: NameFull: Likafi T – PersonEntity: Name: NameFull: Kokola G – PersonEntity: Name: NameFull: Tran S – PersonEntity: Name: NameFull: Kennedy JL – PersonEntity: Name: NameFull: Monroe B – PersonEntity: Name: NameFull: Hughes CM – PersonEntity: Name: NameFull: Joseph T – PersonEntity: Name: NameFull: Person MK – PersonEntity: Name: NameFull: Townsend MB – PersonEntity: Name: NameFull: Satheshkumar PS – PersonEntity: Name: NameFull: Kabamba J – PersonEntity: Name: NameFull: Reynolds MG – PersonEntity: Name: NameFull: Rao AK – PersonEntity: Name: NameFull: Kasongo D – PersonEntity: Name: NameFull: Yu PA – PersonEntity: Name: NameFull: Yu Y – PersonEntity: Name: NameFull: Shongo Lushima R – PersonEntity: Name: NameFull: Kaba D – PersonEntity: Name: NameFull: Petersen B – PersonEntity: Name: NameFull: McCollum AM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1474-4457 Numbering: – Type: volume Value: 26 – Type: issue Value: 6 Titles: – TitleFull: The Lancet. Infectious diseases Type: main |
| ResultId | 1 |